Toxicity testing in the development of anticancer drugs

Lancet Oncology

Volumn 3, Issue 7, 2002, Pages 438-442

  Double, John ^a   Barras, Nigel ^b   Barnard, Neal D ^c   Navaratnam, Vyra ^d  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOSPORIN; CYTOTOXIC AGENT; LOMUSTINE; TAMOXIFEN CITRATE;

ANIMAL RIGHTS; BIOASSAY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; DRUG ACTIVITY; DRUG APPROVAL; DRUG CARCINOGENICITY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; ETHICS; GENOTOXICITY; HUMAN; LICENCE; MAXIMUM TOLERATED DOSE; METHODOLOGY; NONHUMAN; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIDE EFFECT; TOXICITY TESTING; TOXICOLOGY; VOLUNTEER; ANIMAL; DRUG SCREENING; EXPERIMENTAL ANIMAL; REVIEW;

ANIMALS; ANIMALS, LABORATORY; ANTINEOPLASTIC AGENTS; DRUG EVALUATION, PRECLINICAL; HUMANS; TOXICITY TESTS;

EID: 0036636580     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(02)00791-X     Document Type: Note

References (21)

1. Newell DR, Burtles SS, Fox BW, et al. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics. Br J Cancer 1999; 81: 760-68.
2. Leyland-Jones B and Grieshaber CK. Of (only) mice and men. Br J Cancer 1999; 81: 753-55.
3. Newell DR, Burtles SS, Fox BW, et al. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics. Br J Cancer 1999; 81: 760-68.
4. Colombo P, Gunnarsson K, Iatropoulos M, Brughera M. Toxicological testing of cytotoxic drugs. Int J Oncol 2001; 19: 1021-28.
5. Olsen H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and animals. Reg Tox Pharm 2000; 32: 56-67.
6. Lave LB, Ennever FK, Rosenkranz HS, Omenn GS. Information value of the rodent bioassay. Nature 1988; 336: 631-33.
7. Gold LS, Bernstein L, Magaw R, Slone TH. Interspecies extrapolation in carcinogenesis: prediction between rats and mice. Environ Health Perspect 1989; 81: 211-19.
8. Gold LS, Slone TH, Ames BN. What do animal cancer tests tell us about human cancer risk? Overview of analyses of the carcinogenic potency database. Drug Metab Rev 1998; 30: 359-404.
9. Ennever FK, Noonan TJ, Rosenkranz HS. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. Mutagenesis 1987; 2: 73-8.
10. Salsburg D. The lifetime feeding study in mice and rats - an examination of its validity as a bioassay for human carcinogens. Fundam Appl Toxicol 1983; 3: 63-7.
11. Clemedson C, McFarlane-Abdulla E, Andersson M, et al. MEIC evaluation of acute systemic toxicity. ATLA 1996; 24: 273-311.
12. Ashby J, Paton D. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures. Mutat Res 1993; 286: 3-74.
13. Ames BN, Durston WE, Yamasaki E, Lee FD. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 1973; 70: 2281-85.
14. Council Directive 86/609/EECD on the approximation of laws, regulations, and administrative provisions of the member states regarding the protection of animals used for experimental or other scientific purposes. Official J Eur Communities 1986; L358: 1-29.
15. Animals (Scientific Procedures) Act 1986. London: HMSO, 1986.
16. Guidance on the operation of the Animals (Scientific Procedures) Act 1986. London: HMSO, 2000.
17. Code of practice for the housing and care of animals used in scientific procedures. London: HMSO, 1986.
18. The code of practice for the housing and care of animals used in designated breeding and supplying establishments. London: HMSO, 1995.
19. Guidance on the conduct of regulatory toxicology and safety evaluation studies. London: HMSO, 2001.
20. Guidance document on the recognition, assessment, and use of clinical signs as humane endpoints for experimental animals used in safety evaluation. Series on testing and assessment No. 19. Paris: The Organisation of Economic Co-operation and Development (OECD), 2000.
21. Draft guidance document on the development, validation, and regulatory acceptance of new and updated internationally acceptable test methods in hazard assessment. Series on testing and assessment No. 34. The Organisation of Economic Co-operation and Development (OECD), 2001.